entity

CRISPR/Cas9

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CRISPR/Cas9: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

15Connections
0Hypotheses
2Analyses
7Outgoing
0Incoming

Wiki Pages (20)

Knowledge base pages for this entity

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Alpha-Synuclein Pathology

mechanism · 6288 words

Therapeutics

index · 5665 words

TREM2 Mechanism Hub

mechanism · 5099 words

Growth Factor Therapies

therapeutic · 4974 words

Outgoing (15)

TargetRelationTypeStr
Mutant Gene Expressioninhibitsprocess0.85
SOD1targetsgene0.85
APOEtargetsgene0.85
TREM2targetsgene0.85
ALS-Associated Mutationstargetsbiomarker0.80

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.622

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-02 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found